Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Dec;49(4):211-3.
doi: 10.5045/br.2014.49.4.211.

The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria

Affiliations
Review

The puzzle of myeloproliferative neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria

Hee-Jin Kim et al. Blood Res. 2014 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

No potential conflicts of interest relevant to this article were reported.

References

    1. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of tumours of haematopoietic and lymphoid tissues. 4th ed. France: IARC Press; 2008.
    1. Tefferi A, Thiele J, Vannucchi AM, Barbui T. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia. 2014;28:1407–1413. - PubMed
    1. Rumi E, Pietra D, Ferretti V, et al. JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes. Blood. 2014;123:1544–1551. - PMC - PubMed
    1. Tefferi A, Lasho TL, Finke C, et al. Type 1 vs type 2 calreticulin mutations in primary myelofibrosis: differences in phenotype and prognostic impact. Leukemia. 2014;28:1568–1570. - PubMed
    1. Barbui T, Thiele J, Carobbio A, et al. Discriminating between essential thrombocythemia and masked polycythemia vera in JAK2 mutated patients. Am J Hematol. 2014;89:588–590. - PubMed

LinkOut - more resources